Structural insights into the regulation of phosphodiesterase 4 lead to the discovery of allosteric modulators with reduced side effects.
References
Conti, M. & Beavo, J. Annu. Rev. Biochem. 76, 481–511 (2007).
Houslay, M.D., Baillie, G.S. & Maurice, D.H. Circ. Res. 100, 950–966 (2007).
Houslay, M.D., Schafer, P. & Zhang, K.Y. Drug Discov Today 10, 1503–1519 (2005).
Burgin, A. et al. Nat. Biotechnol. 27, 63–70 (2010).
Beard, M.B. et al. J. Biol. Chem. 275, 10349–10358 (2000).
Lim, J., Pahlke, G. & Conti, M. J. Biol. Chem. 274, 19677–19685 (1999).
Xu, R.X. et al. Science 288, 1822–1825 (2000).
Wang, H. et al. Biochem. J. 408, 193–201, (2007).
McPhee, I. et al. J. Biol. Chem. 274, 11796–11810 (1999).
Bolger, G.B. et al. Biochem. J. 398, 23–36, (2006).
Terry, R. et al., Cell. Signal. 15, 955–971 (2003)
Robichaud, A. et al. J. Clin. Invest. 110, 1045–1052 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Houslay, M., Adams, D. Putting the lid on phosphodiesterase 4. Nat Biotechnol 28, 38–40 (2010). https://doi.org/10.1038/nbt0110-38
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0110-38
- Springer Nature America, Inc.
This article is cited by
-
Advances in targeting cyclic nucleotide phosphodiesterases
Nature Reviews Drug Discovery (2014)
-
An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing
BMC Evolutionary Biology (2010)
-
Phosphodiesterase 4D, cAMP specific
AfCS-Nature Molecule Pages (2010)